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Retinoblastoma, our experience 
Retinoblastoma is the most frequent intraocular tumor in childhood 
(Incidence 1:15 000/20 000 births). In Portugal 5-6 cases/year 
  
Caused by a mutation in the RB1 tumor suppressor gene and both copies of the gene must 
be mutated in order for a tumor to form. 
This mutation may be nonheritable (60%) or heritable (40%), the latter by autosomal-
dominant transmission with high penetrance. 
 
Retinoblastoma is typically diagnosed during the 1st year in familial and bilateral cases and 
between ages 1 - 3 in sporadic unilateral cases. There is no gender or race predilection. 
 
Late diagnosis usually means lost of eye function or even death, that is why early diagnosis 
and treatment is so critical to preserve life, eye and vision, the key of success. 
Presentation Number of cases (%) 
Goddard 
et al2 
Abramson 
et al3 
Leukocoria 52 54 
Strabismus 29 19 
Changes in the 
appearance of the 
eye 
10 5 
Visual acuity 
decrease 
9 4 
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International Intraocular Retinoblastoma 
Classification 
Group A- Very low risk 
Group B- Low risk 
Group C- Moderate risk 
Group D- High risk 
Group E- Very high risk 
Therapeutic approaches 
Enucleation Thermotherapy 
Local chemotherapy 
 
Brachytherapy 
Cryotherapy  Radiotherapy by protons 
beam irradiation 
Photocoagulation Systemic chemotherapy  
Retrospective analysis of patients diagnosed with retinoblastoma, observed and submitted to treatment at Hospital Prof. Doutor Fernando Fonseca (HFF), with collaboration of Instituto Português de Oncologia de Lisboa (IPO) and Hôpital Ophthalmique Jules-Gonin 
(HJG), in the last 8 years (2004-2012). Presentation of a case. 
Variable Laterality Global 
unilateral bilateral 
Nº of patients 7 (64%) 4 (36%) 11 
Nº of eyes 7 8 15 
Average age at 
diagnosis (months) 
28 8 21 
Gender 
(F/M) 
5/2 1/3 6/5 (54%/46%) 
Race (caucasian/ black) 6/1 2/2 8/3 (73%/27%) 
Family history - 1 1 (9%) 
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Presentation Number of patients 
Asymptomatic 
(screening) 
2 (18%) 
(1- family history; 1- prematurity) 
Leukocoria 7 (64%) 
Strabismus 2 (18%) 
Stage Number of eyes 
A 3 (20%) 
B 3 (20%) 
C - 
D 6 (40%) 
E 3 (20%) T
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Treatment Number of eyes 
HFF/IPO HJG 
Systemic chemotherapy 15 (100%) - 
Photocoagulation 11 (73%) - 
Cryotherapy 10 (66%) - 
Transpupillary termotherapy 
(Diode LASER) 
- 6 (40%) 
Radiotherapy  - 3 (20%) 
Local chemotherapy 
(intravitreal or intraarterial) 
-  2 (13%) 
Primary enucleation 4 (27%) - 
Secondary enucleation 3 (20%) - T
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Parameters Laterality Total 
unilateral bilateral 
Nº of eyes 7 8  15 
Conservative 
treatment ( nº 
of eyes) 
4 (27%) 4 (27%) 8 (53%) 
Enucleation (nº 
of eyes) 
3 (20%) 4 (27%) 7 (47%) 
Bilateral 
enucleation 
(nº of patients) 
- 1  - 
4 Months old, family history of Retinoblastoma 
Retinoblastoma (stage A: < 3mm) on both eyes 
 Before treatment After treatment 
15 days: 
scarring lesions 
Relapse 6 months 
after first treatment 
After 5 years: no sign of relapse 
Visual acuity 1.0 (both eyes) 
OD 
OD 
OD 
OS 
OD 
OD 
OD 
OS 
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The best treatment 
is, and will always 
be, early diagnosis 
and treatment 
Immediately 
